Patent ID: 11958855
Assignee: MILLENNIUM PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The method of claim 1, wherein the therapeutic agent is capecitabine, gemcitabine, 5-fluorouracil, 5-fluorouracil/leucovorin, fludarabine, cytarabine, mercaptopurine, thioguanine, pentostatin, methotrexate, etoposide, teniposide, camptothecin, topotecan, irinotecan, doxorubicin, daunorubicin, vincristine, vinblastine, paclitaxel, docetaxel, cisplatin, carboplatin, oxaliplatin, actinomycin D, bleomycin, mitomycin C, adriamycin, daunorubicin, idarubicin, doxorubicin, pegylated liposomal doxorubicin, melphalan, chlorambucil, busulfan, thiotepa, ifosfamide, carmustine, lomustine, semustine, streptozocin, dacarbazine, cyclophosphamide, thalidomide, CC-5013, CC-4047, imatinib mesylate, gefitinib, trastuzumab, rituximab, cetuximab, bevacizumab, mitoxantrone, dexamethasone, prednisone, or temozolomide.